Stockscreener 앱 받기
1.7803
5.08%
0.0803
Pacific Biosciences Of California Inc 주식(PACB)의 최신 뉴스
Pacific Biosciences of California (NASDAQ:PACB) Trading 8.5% HigherShould You Buy? - MarketBeat
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now - Yahoo Finance
Cantor Fitzgerald Comments on PACB FY2025 Earnings - MarketBeat
PACB Stock Falls on Preliminary Q4 Sales Miss, 7 Vega Systems Shipped - MSN
PACB Stock Rises After the Shipment of Vega Systems to Berry Genomics - MSN
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report - GlobeNewswire Inc.
Chromosome-level genome assembly of the pine wood nematode carrier Arhopalus unicolor - Nature.com
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now - MSN
PacBio announces preliminary Q4 revenue of $39.2M - MSN
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap DownShould You Sell? - MarketBeat
PacBio Stock May Gain Following the Collaborated Launch of GutID - MSN
PACB Stock Declines Despite Promising HiFi Sequencing Findings - Yahoo Finance
Don't Ignore The Insider Selling In Pacific Biosciences of California - Simply Wall St
Selling Pacific Biosciences of California Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Bought by Barclays PLC - MarketBeat
PacBio reports drop in annual revenue, launches new products By Investing.com - Investing.com Canada
PacBio reports drop in annual revenue, launches new products - Investing.com India
PacBio's HiFi Sequencing Achieves 93% Success Rate in Breakthrough Rare Disease Study - StockTitan
PacBio Reports 33% Revenue Decline Despite Launch of New Vega System and Sub-$500 Genome Sequencing - StockTitan
Pacific Biosciences COO Mark Van Oene sells shares for $69,979 - Investing.com India
Whole genome sequencing, assembly and annotation of the Southern Ground Hornbill – Bucorvus leadbeateri - Nature.com
Pacific Biosciences COO Mark Van Oene sells shares for $69,979 By Investing.com - Investing.com Canada
Insider Selling: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells 34,405 Shares of Stock - MarketBeat
Pacbio and Intus Bio Collaborate for Launch of Gutid - Marketscreener.com
PacBio Launches GutID: Revolutionary At-Home Microbiome Test Using HiFi Sequencing - StockTitan
Pacific Biosciences of California (NASDAQ:PACB) Upgraded to Sell at StockNews.com - MarketBeat
PacBio delivers first Vega systems to Berry Genomics By Investing.com - Investing.com Nigeria
PacBio delivers first Vega systems to Berry Genomics - Investing.com
PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets - Quantisnow
Why the Market Dipped But Pacific Biosciences of California (PACB) Gained Today - MSN
PacBio Delivers First Vega DNA Sequencers to Berry Genomics in Major China Expansion - StockTitan
Pacific Biosciences of California (NASDAQ:PACB) Stock Price Up 7.2%What's Next? - MarketBeat
Pacific Biosciences of California Sees Unusually Large Options Volume (NASDAQ:PACB) - MarketBeat
PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference - Quantisnow
Barclays PLC Boosts Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat
Chromosome-level genome assembly of Triplophysa bombifrons using PacBio HiFi sequencing and Hi-C technologies - Nature.com
Why Is Pacific Biosciences of California, Inc. (PACB) Among the Top CRISPR Stocks to Invest In? - Insider Monkey
Top 11 CRISPR Stocks to Invest In - Insider Monkey
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $2.95 Consensus Target Price from Analysts - MarketBeat
State Street Corp Boosts Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat
Third Generation Sequencing Market Key Players Analysis - openPR
Reasons to Retain PacBio Stock in Your Portfolio for Now - MSN
0.89%
0.24%
자본화:
|
볼륨(24시간):